{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:23:18Z","timestamp":1787678598216,"version":"build-2784847793"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05419-1","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:34:16Z","timestamp":1779417256000},"page":"16729-16756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives"],"prefix":"10.1007","volume":"399","author":[{"given":"Mokhtar","family":"Rejili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar R.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabat J.","family":"Al-Maiahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"5419_CR1","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1111\/nmo.12154","volume":"25","author":"M Aguilera","year":"2013","unstructured":"Aguilera M, Vergara P, Mart\u00ednez V (2013) Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterol Motil 25:e515\u2013e529","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","volume":"590","author":"J Aguilera-Lizarraga","year":"2021","unstructured":"Aguilera-Lizarraga J, Florens MV, Viola MF, Jain P, Decraecker L, Appeltans I, Cuende-Estevez M, Fabre N, VAN Beek K, Perna E, Balemans D, Stakenborg N, Theofanous S, Bosmans G, Mondelaers SU, Matteoli G, Ibiza Mart\u00ednez S, Lopez-Lopez C, Jaramillo-Polanco J, Talavera K, Alpizar YA, Feyerabend TB, Rodewald HR, Farre R, Redegeld FA, Si J, Raes J, Breynaert C, Schrijvers R, Bosteels C, Lambrecht BN, Boyd SD, Hoh RA, Cabooter D, Nelis M, Augustijns P, Hendrix S, Strid J, Bisschops R, Reed DE, Vanner SJ, Denadai-Souza A, Wouters MM, Boeckxstaens GE (2021) Local immune response to food antigens drives meal-induced abdominal pain. Nature 590:151\u2013156","journal-title":"Nature"},{"key":"5419_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41577-022-00700-9","volume":"22","author":"J Aguilera-Lizarraga","year":"2022","unstructured":"Aguilera-Lizarraga J, Hussein H, Boeckxstaens GE (2022) Immune activation in irritable bowel syndrome: what is the evidence? Nat Rev Immunol 22:674\u2013686","journal-title":"Nat Rev Immunol"},{"key":"5419_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74934-9","volume":"10","author":"Y Ait Chait","year":"2020","unstructured":"Ait Chait Y, Mottawea W, Tompkins TA, Hammami R (2020) Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep 10:17878","journal-title":"Sci Rep"},{"key":"5419_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113485","volume":"23","author":"A Alchakee","year":"2022","unstructured":"Alchakee A, Ahmed M, Eldohaji L, Alhaj H, Saber-Ayad M (2022) Pharmacogenomics in psychiatry practice: the value and the challenges. Int J Mol Sci 23:13485","journal-title":"Int J Mol Sci"},{"key":"5419_CR6","doi-asserted-by":"publisher","unstructured":"Alhabeeb H, Alfaiz A, Kutbi E, Alshahrani D, Alsuhail A, Alrajhi S, Alotaibi N, Alotaibi K, Alamri S, Alghamdi S, Aljohani N (2021) Gut hormones in health and obesity: the upcoming role of short chain fatty acids. Nutrients\u00a013(2):481. https:\/\/doi.org\/10.3390\/nu13020481","DOI":"10.3390\/nu13020481"},{"key":"5419_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.191","volume":"6","author":"AP Allen","year":"2016","unstructured":"Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, Murphy E, Cryan JF, Dinan TG, Clarke G (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6:e939","journal-title":"Transl Psychiatry"},{"key":"5419_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.dld.2020.11.026","volume":"53","author":"A Ancona","year":"2021","unstructured":"Ancona A, Petito C, Iavarone I, Petito V, Galasso L, Leonetti A, Turchini L, Belella D, Ferrarrese D, Addolorato G, Armuzzi A, Gasbarrini A, Scaldaferri F (2021) The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease. Dig Liver Dis 53:298\u2013305","journal-title":"Dig Liver Dis"},{"key":"5419_CR9","doi-asserted-by":"publisher","unstructured":"Appleton KM, Sallis HM, Perry R, Ness AR, Churchill R (2015) Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev CD004692. https:\/\/doi.org\/10.1002\/14651858.CD004692.pub4","DOI":"10.1002\/14651858.CD004692.pub4"},{"key":"5419_CR10","unstructured":"Appleton J (2018) The gut-brain axis: influence of microbiota on mood and mental health. Integr Med: A Clin J 17:28"},{"key":"5419_CR11","doi-asserted-by":"crossref","unstructured":"Balda\u00e7ara L (2024) Duloxetine: an update. Res, Soc Dev 13:e7313345331\u2013e7313345331","DOI":"10.33448\/rsd-v13i3.45331"},{"key":"5419_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1297231","volume":"14","author":"SS Banihashem","year":"2023","unstructured":"Banihashem SS, Mofatioshieh SM, Rastegar R, Sadeghi A (2023) Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia - a randomized clinical trial. Front Psychiatry 14:1297231","journal-title":"Front Psychiatry"},{"key":"5419_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000370047","volume":"71","author":"J Beck","year":"2015","unstructured":"Beck J, Bruni N, Brand S, Holsboer-Trachsler E (2015) Repeated cortisol awakening response as predictor of antidepressant treatment outcome with duloxetine. Neuropsychobiology 71:97\u2013102","journal-title":"Neuropsychobiology"},{"key":"5419_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/ajg.2016.223","volume":"111","author":"SM Bennet","year":"2016","unstructured":"Bennet SM, Polster A, T\u00f6rnblom H, Isaksson S, Capronnier S, Tessier A, LE Nev\u00e9 B, Simr\u00e9n M, \u00d6hman L (2016) Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome. Am J Gastroenterol 111:1165\u201376","journal-title":"Am J Gastroenterol"},{"key":"5419_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41431-024-01648-1","volume":"32","author":"L Beunk","year":"2024","unstructured":"Beunk L, Nijenhuis M, Soree B, DE Boer-Veger NJ, Buunk AM, Guchelaar HJ, Houwink EJF, Risselada A, Rongen G, VAN Schaik RHN, Swen JJ, Touw D, Deneer VHM, VAN Westrhenen R (2024) Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI\/non-TCA antidepressants. Eur J Hum Genet 32:1371\u20131377","journal-title":"Eur J Hum Genet"},{"key":"5419_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/apt.16322","volume":"53","author":"CJ Black","year":"2021","unstructured":"Black CJ, Yiannakou Y, Guthrie E, West R, Houghton LA, Ford AC (2021) Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value. Aliment Pharmacol Ther 53:1126\u20131137","journal-title":"Aliment Pharmacol Ther"},{"key":"5419_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jpsychores.2007.10.010","volume":"64","author":"EB Blanchard","year":"2008","unstructured":"Blanchard EB, Lackner JM, Jaccard J, Rowell D, Carosella AM, Powell C, Sanders K, Krasner S, Kuhn E (2008) The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 64:119\u2013128","journal-title":"J Psychosom Res"},{"key":"5419_CR18","doi-asserted-by":"publisher","unstructured":"Blase K, Vermetten E, Lehrer P, Gevirtz R (2021) Neurophysiological Approach by Self-Control of Your Stress-Related Autonomic Nervous System with Depression, Stress and Anxiety Patients. Int J Environ Res Public Health 18(7):3329. https:\/\/doi.org\/10.3390\/ijerph18073329","DOI":"10.3390\/ijerph18073329"},{"key":"5419_CR19","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:16050\u201316055","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5419_CR20","first-page":"8846","volume":"20","author":"MM Buckley","year":"2014","unstructured":"Buckley MM, O\u2019mahony SM, O\u2019malley D (2014) Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 20:8846\u201358","journal-title":"World J Gastroenterol"},{"key":"5419_CR21","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203\u2013209","journal-title":"Ann Gastroenterol"},{"key":"5419_CR22","doi-asserted-by":"crossref","unstructured":"Cario E (2020) Recognition of microbe-associated molecular patterns by pattern recognition receptors. Princ Mucosal Immunol 269\u2013283","DOI":"10.1201\/9781317212942-18"},{"key":"5419_CR23","doi-asserted-by":"publisher","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","volume":"301","author":"IM Carroll","year":"2011","unstructured":"Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y (2011) Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301:G799-807","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5419_CR24","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.42747","volume":"7","author":"L Chen","year":"2017","unstructured":"Chen L, Ilham SJ, Feng B (2017) Pharmacological approach for managing pain in irritable bowel syndrome: a review article. Anesth Pain Med 7:e42747","journal-title":"Anesth Pain Med"},{"key":"5419_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jns.2015.10.001","volume":"358","author":"H-S Choi","year":"2015","unstructured":"Choi H-S, Park JH, Ahn JH, Hong S, Cho JH, Won M-H, Lee C-H (2015) The anti-inflammatory activity of duloxetine, a serotonin\/norepinephrine reuptake inhibitor, prevents kainic acid-induced hippocampal neuronal death in mice. J Neurol Sci 358:390\u2013397","journal-title":"J Neurol Sci"},{"key":"5419_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4103\/1735-1995.165969","volume":"20","author":"H Daghaghzadeh","year":"2015","unstructured":"Daghaghzadeh H, Naji F, Afshar H, Sharbafchi MR, Feizi A, Maroufi M, Tabatabaeeyan M, Adibi P, Tavakoli H (2015) Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double-blind controlled study. J Res Med Sci 20:595\u2013601","journal-title":"J Res Med Sci"},{"key":"5419_CR27","doi-asserted-by":"publisher","unstructured":"De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, Pinto-Sanchez MI, Philip V, Mclean PG, Hagelsieb MG, Surette MG, Bergonzelli GE, Verdu EF, Britz-Mckibbin P, Neufeld JD, Collins SM, Bercik P (2017) Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med 9(379):eaaf6397. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6397","DOI":"10.1126\/scitranslmed.aaf6397"},{"key":"5419_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.neuroimage.2009.05.074","volume":"47","author":"K Dedovic","year":"2009","unstructured":"Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC (2009) The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage 47:864\u2013871","journal-title":"Neuroimage"},{"key":"5419_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","volume":"130","author":"TG Dinan","year":"2006","unstructured":"Dinan TG, Quigley EM, Ahmed SM, Scully P, O\u2019Brien S, O\u2019Mahony L, O\u2019Mahony S, Shanahan F, Keeling PN (2006) Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130:304\u2013311","journal-title":"Gastroenterology"},{"key":"5419_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2015.02.021","volume":"63","author":"TG Dinan","year":"2015","unstructured":"Dinan TG, Stilling RM, Stanton C, Cryan JF (2015) Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res 63:1\u20139","journal-title":"J Psychiatr Res"},{"key":"5419_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175499","volume":"941","author":"H Ding","year":"2023","unstructured":"Ding H, Gao Y, Wang Y, Yao K, Wang G, Zhang J (2023) The role of peripheral serotonin and norepinephrine in the gastroprotective effect against stress of duloxetine. Eur J Pharmacol 941:175499","journal-title":"Eur J Pharmacol"},{"key":"5419_CR32","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3748\/wjg.v22.i7.2219","volume":"22","author":"E Distrutti","year":"2016","unstructured":"Distrutti E, Monaldi L, Ricci P, Fiorucci S (2016) Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J Gastroenterol 22:2219\u201341","journal-title":"World J Gastroenterol"},{"key":"5419_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.813075","volume":"16","author":"Z Dong","year":"2022","unstructured":"Dong Z, Shen X, Hao Y, Li J, Xu H, Yin L, Kuang W (2022) Gut microbiome: a potential indicator for predicting treatment outcomes in major depressive disorder. Front Neurosci 16:813075","journal-title":"Front Neurosci"},{"key":"5419_CR34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL (2016) Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150:1257\u20131261","journal-title":"Gastroenterology"},{"key":"5419_CR35","doi-asserted-by":"publisher","unstructured":"Drossman DA (2016) Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology S0016-5085(16)00223-7. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.032","DOI":"10.1053\/j.gastro.2016.02.032"},{"key":"5419_CR36","doi-asserted-by":"publisher","unstructured":"Dudzi\u0144ska\u00a0E, Grabrucker AM, Kwiatkowski P, Sitarz R, Sienkiewicz M (2023) The importance of visceral hypersensitivity in irritable bowel syndrome-plant metabolites in IBS treatment. Pharmaceuticals (Basel) 16(10):1405. https:\/\/doi.org\/10.3390\/ph16101405","DOI":"10.3390\/ph16101405"},{"key":"5419_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/13651501.2011.572169","volume":"15","author":"H Due\u00f1as","year":"2011","unstructured":"Due\u00f1as H, Lee A, Brnabic AJ, Chung KF, Lai CH, Badr MG, Uy-Ponio T, Ruiz JR, Varrey P, Jian H, Dossenbach M (2011) Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. Int J Psychiatry Clin Pract 15:80\u201390","journal-title":"Int J Psychiatry Clin Pract"},{"key":"5419_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejphar.2007.11.069","volume":"583","author":"AJ Dunn","year":"2008","unstructured":"Dunn AJ, Swiergiel AH (2008) The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems. Eur J Pharmacol 583:186\u2013193","journal-title":"Eur J Pharmacol"},{"key":"5419_CR39","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2014-307997","volume":"64","author":"WE Ek","year":"2015","unstructured":"Ek WE, Reznichenko A, Ripke S, Niesler B, Zucchelli M, Rivera NV, Schmidt PT, Pedersen NL, Magnusson P, Talley NJ, Holliday EG, Houghton L, Gazouli M, Karamanolis G, Rappold G, Burwinkel B, Surowy H, Rafter J, Assadi G, Li L, Papadaki E, Gambaccini D, Marchi S, Colucci R, Blandizzi C, Barbaro R, Karling P, Walter S, Ohlsson B, Tornblom H, Bresso F, Andreasson A, Dlugosz A, Simren M, Agreus L, Lindberg G, Boeckxstaens G, Bellini M, Stanghellini V, Barbara G, Daly MJ, Camilleri M, Wouters MM, D\u2019amato M (2015) Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut 64:1774\u201382","journal-title":"Gut"},{"key":"5419_CR40","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1021\/acsptsci.4c00506","volume":"7","author":"MS Elgawish","year":"2024","unstructured":"Elgawish MS, Atta AM, Hafeez SM, Abdel Mageed SS, Mahmoud AMA, Moustafa MA, Ali MA (2024) Investigation of pharmacokinetic and pharmacodynamic interactions between citalopram and duloxetine: an integrated analytical, computational, behavioral, and biochemical approach. ACS Pharmacol Transl Sci 7:4032\u20134042","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5419_CR41","doi-asserted-by":"publisher","unstructured":"Fadgyas Stanculete M, Dumitrascu DL, Drossman D.\u00a0(2021) Neuromodulators in the brain-gut Axis: Their role in the therapy of the irritable bowel syndrome. J Gastrointest Liver Dis\u00a030(4):517\u2013525. https:\/\/doi.org\/10.15403\/jgld-4090","DOI":"10.15403\/jgld-4090"},{"key":"5419_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040657","author":"E Fock","year":"2023","unstructured":"Fock E, Parnova R (2023) Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids. Cells. https:\/\/doi.org\/10.3390\/cells12040657","journal-title":"Cells"},{"key":"5419_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gut.2008.163162","volume":"58","author":"AC Ford","year":"2009","unstructured":"Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P (2009) Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58:367\u2013378","journal-title":"Gut"},{"key":"5419_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","volume":"396","author":"AC Ford","year":"2020","unstructured":"Ford AC, Sperber AD, Corsetti M, Camilleri M (2020) Irritable bowel syndrome. Lancet 396:1675\u20131688","journal-title":"Lancet"},{"key":"5419_CR45","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","volume":"402","author":"AC Ford","year":"2023","unstructured":"Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA (2023) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402:1773\u20131785","journal-title":"Lancet"},{"key":"5419_CR46","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1185\/03007995.2011.633502","volume":"27","author":"EP Frakes","year":"2011","unstructured":"Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM (2011) Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin 27:2361\u20132372","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 17","key":"5419_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00535-006-1942-7","volume":"42","author":"S Fukudo","year":"2007","unstructured":"Fukudo S (2007) Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol 42(Suppl 17):48\u201351","journal-title":"J Gastroenterol"},{"key":"5419_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.neuroimage.2009.04.083","volume":"47","author":"S Fukudo","year":"2009","unstructured":"Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M (2009) Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 47:946\u2013951","journal-title":"Neuroimage"},{"key":"5419_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fphar.2011.00028","volume":"2","author":"JD Gale","year":"2011","unstructured":"Gale JD, Houghton LA (2011) Alpha 2 delta (\u03b1(2)\u03b4) ligands, Gabapentin and Pregabalin: what is the evidence for potential use of these ligands in irritable bowel syndrome. Front Pharmacol 2:28","journal-title":"Front Pharmacol"},{"key":"5419_CR50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jad.2024.10.042","volume":"369","author":"J Gamboa","year":"2025","unstructured":"Gamboa J, Le GH, Wong S, Alteza EAI, Zachos KA, Teopiz KM, McIntyre RS (2025) Impact of antidepressants on the composition of the gut microbiome: a systematic review and meta-analysis of in vivo studies. J Affect Disord 369:819\u2013833","journal-title":"J Affect Disord"},{"key":"5419_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-05910-0","volume":"24","author":"W Gao","year":"2024","unstructured":"Gao W, Gao Y, Xu Y, Liang J, Sun Y, Zhang Y, Shan F, Ge J, Xia Q (2024) Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder. BMC Psychiatry 24:449","journal-title":"BMC Psychiatry"},{"key":"5419_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2982.2007.01026.x","volume":"20","author":"AB Grudell","year":"2008","unstructured":"Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR (2008) An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 20:213\u2013219","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/10401230701333319","volume":"19","author":"S Gupta","year":"2007","unstructured":"Gupta S, Nihalani N, Masand P (2007) Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Ann Clin Psychiatry 19:125\u2013132","journal-title":"Ann Clin Psychiatry"},{"key":"5419_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"EP Halmos","year":"2014","unstructured":"Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146:67-75.e5","journal-title":"Gastroenterology"},{"key":"5419_CR55","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1572-0241.2005.30375.x","volume":"100","author":"A Halpert","year":"2005","unstructured":"Halpert A, Dalton CB, Diamant NE, Toner BB, Hu Y, Morris CB, Bangdiwala SI, Whitehead WE, Drossman DA (2005) Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage. Am J Gastroenterol 100:664\u2013671","journal-title":"Am J Gastroenterol"},{"key":"5419_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/1756284821993586","volume":"14","author":"N Hanning","year":"2021","unstructured":"Hanning N, Edwinson AL, Ceuleers H, Peters SA, DE Man JG, Hassett LC, DE Winter BY, Grover M (2021) Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol 14:1756284821993586","journal-title":"Therap Adv Gastroenterol"},{"key":"5419_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14339","volume":"34","author":"WL Hasler","year":"2022","unstructured":"Hasler WL, Grabauskas G, Singh P, Owyang C (2022) Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. Neurogastroenterol Motil 34:e14339","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/zeb.2013.0917","volume":"11","author":"Q He","year":"2014","unstructured":"He Q, Wang L, Wang F, Li Q (2014) Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways. Zebrafish 11:255\u2013264","journal-title":"Zebrafish"},{"key":"5419_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3748\/wjg.v28.i4.412","volume":"28","author":"EMR Hillestad","year":"2022","unstructured":"Hillestad EMR, VAN DER Meeren A, Nagaraja BH, Bj\u00f8rsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B (2022) Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 28:412\u2013431","journal-title":"World J Gastroenterol"},{"key":"5419_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/bcpt.13954","volume":"134","author":"K Hole","year":"2024","unstructured":"Hole K, Gangs\u00f8 S, Jensstuen \u00c5 T, Orm\u00f8y HH, Paulsen M, Molden E, Haslemo T (2024) Effect of CYP2D6 genotype on duloxetine serum concentration. Basic Clin Pharmacol Toxicol 134:186\u2013192","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5419_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coph.2015.09.003","volume":"25","author":"P Holzer","year":"2015","unstructured":"Holzer P, Hassan AM, Jain P, Reichmann F, Farzi A (2015) Neuroimmune pharmacological approaches. Curr Opin Pharmacol 25:13\u201322","journal-title":"Curr Opin Pharmacol"},{"key":"5419_CR62","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.3748\/wjg.v29.i26.4120","volume":"29","author":"KY Huang","year":"2023","unstructured":"Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L (2023) Irritable bowel syndrome: epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 29:4120\u20134135","journal-title":"World J Gastroenterol"},{"key":"5419_CR63","unstructured":"Illendula S, Telu G, Tabassum F, Sushmitha D, Naik G, Hemalatha G, Suresh C, Rao K (2022) New spectrophotometric method development for the estimation of duloxetine HCl in bulk and pharmaceutical dosage form. Int J Res 11:14\u201324"},{"key":"5419_CR64","first-page":"45","volume":"15","author":"S Jafari","year":"2022","unstructured":"Jafari S, Sajedi B, Jameshorani M, Salarpour F (2022) Comparison of fluoxetine and duloxetine hydrochloride therapeutic effects on patients with constipation-predominant irritable bowel syndrome. Gastroenterol Hepatol Bed Bench 15:45\u201352","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"5419_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.61186\/jambr.32.150.33","volume":"32","author":"S Jafari","year":"2024","unstructured":"Jafari S, Khalili Mahani S, Mohsen-Pour N (2024) Comparison of the effect of duloxetine and imipramine in the treatment of patients with diarrhea dominant irritable bowel syndrome. J Adv Med Biomed Res 32:33\u201340","journal-title":"J Adv Med Biomed Res"},{"key":"5419_CR66","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/gutjnl-2011-301501","volume":"61","author":"IB Jeffery","year":"2012","unstructured":"Jeffery IB, O\u2019toole PW, \u00d6hman L, Claesson MJ, Deane J, Quigley EM, Simr\u00e9n M (2012) An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61:997\u20131006","journal-title":"Gut"},{"key":"5419_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejpain.2006.02.008","volume":"11","author":"CK Jones","year":"2007","unstructured":"Jones CK, Peters SC, Shannon HE (2007) Synergistic interactions between the dual serotonergic, noradrenergic reuptake inhibitor duloxetine and the non-steroidal anti-inflammatory drug ibuprofen in inflammatory pain in rodents. Eur J Pain 11:208\u2013215","journal-title":"Eur J Pain"},{"issue":"Suppl 3","key":"5419_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1440-1746.2011.06640.x","volume":"26","author":"M Kanazawa","year":"2011","unstructured":"Kanazawa M, Hongo M, Fukudo S (2011) Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol 26(Suppl 3):119\u2013121","journal-title":"J Gastroenterol Hepatol"},{"key":"5419_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09635-x","volume":"7","author":"M Kano","year":"2017","unstructured":"Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S (2017) Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome. Sci Rep 7:12425","journal-title":"Sci Rep"},{"key":"5419_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/13651501.2013.838632","volume":"18","author":"A Kaplan","year":"2014","unstructured":"Kaplan A, Franzen MD, Nickell PV, Ransom D, Lebovitz PJ (2014) An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder. Int J Psychiatry Clin Pract 18:11\u201315","journal-title":"Int J Psychiatry Clin Pract"},{"key":"5419_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol 14:1118529","journal-title":"Front Microbiol"},{"key":"5419_CR72","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1128\/IAI.00348-16","volume":"84","author":"A Keselman","year":"2016","unstructured":"Keselman A, Li E, Maloney J, Singer SM (2016) The microbiota contributes to CD8+ T cell activation and nutrient malabsorption following intestinal infection with Giardia duodenalis. Infect Immun 84:2853\u20132860","journal-title":"Infect Immun"},{"key":"5419_CR73","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(25)00051-2","volume":"10","author":"M Khasawneh","year":"2025","unstructured":"Khasawneh M, Mokhtare M, Moayyedi P, Black CJ, Ford AC (2025) Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol 10:537\u2013549","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5419_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123183","volume":"10","author":"LA Kilpatrick","year":"2015","unstructured":"Kilpatrick LA, Mayer EA, Labus JS, Gupta A, Hamaguchi T, Mizuno T, Komuro H, Kano M, Kanazawa M, Aoki M, Fukudo S (2015) Serotonin transporter gene polymorphism modulates activity and connectivity within an emotional arousal network of healthy men during an aversive visceral stimulus. PLoS One 10:e0123183","journal-title":"PLoS One"},{"key":"5419_CR75","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","volume":"50","author":"MP Knadler","year":"2011","unstructured":"Knadler MP, Lobo E, Chappell J, Bergstrom R (2011) Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 50:281\u2013294","journal-title":"Clin Pharmacokinet"},{"key":"5419_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jchemneu.2013.05.003","volume":"54","author":"KJ Kov\u00e1cs","year":"2013","unstructured":"Kov\u00e1cs KJ (2013) CRH: the link between hormonal-, metabolic- and behavioral responses to stress. J Chem Neuroanat 54:25\u201333","journal-title":"J Chem Neuroanat"},{"key":"5419_CR77","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3748\/wjg.14.731","volume":"14","author":"JH La","year":"2008","unstructured":"La JH, Sung TS, Kim HJ, Kim TW, Kang TM, Yang IS (2008) Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats. World J Gastroenterol 14:731\u2013736","journal-title":"World J Gastroenterol"},{"key":"5419_CR78","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2982.2011.01867.x","volume":"24","author":"M Larauche","year":"2012","unstructured":"Larauche M (2012) Novel insights in the role of peripheral corticotropin-releasing factor and mast cells in stress-induced visceral hypersensitivity. Neurogastroenterol Motil 24:201\u20135","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR79","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5056\/jnm.2011.17.3.213","volume":"17","author":"M Larauche","year":"2011","unstructured":"Larauche M, Mulak A, Tach\u00e9 Y (2011) Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. J Neurogastroenterol Motil 17:213\u201334","journal-title":"J Neurogastroenterol Motil"},{"key":"5419_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.expneurol.2011.04.020","volume":"233","author":"M Larauche","year":"2012","unstructured":"Larauche M, Mulak A, Tach\u00e9 Y (2012) Stress and visceral pain: from animal models to clinical therapies. Exp Neurol 233:49\u201367","journal-title":"Exp Neurol"},{"key":"5419_CR81","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5056\/jnm16220","volume":"23","author":"C Lee","year":"2017","unstructured":"Lee C, Doo E, Choi JM, Jang SH, Ryu HS, Lee JY, Oh JH, Park JH, Kim YS (2017) The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil 23:349\u2013362","journal-title":"J Neurogastroenterol Motil"},{"key":"5419_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5009\/gnl220346","volume":"18","author":"YF Liang","year":"2024","unstructured":"Liang YF, Chen XQ, Zhang MT, Tang HY, Shen GM (2024) Research progress of central and peripheral corticotropin-releasing hormone in irritable bowel syndrome with comorbid dysthymic disorders. Gut Liver 18:391\u2013403","journal-title":"Gut Liver"},{"key":"5419_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-450","volume":"15","author":"IA Lipkovich","year":"2014","unstructured":"Lipkovich IA, Choy EH, VAN Wambeke P, Deberdt W, Sagman D (2014) Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients. BMC Musculoskelet Disord 15:450","journal-title":"BMC Musculoskelet Disord"},{"key":"5419_CR84","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/DDDT.S216056","volume":"14","author":"R Liu","year":"2020","unstructured":"Liu R, Staller K (2020) Update on Eluxadoline for the treatment of irritable bowel syndrome with diarrhea: patient selection and perspectives. Drug Des Devel Ther 14:1391\u20131400","journal-title":"Drug Des Devel Ther"},{"key":"5419_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.634897","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang J, Wu C (2021) Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics. Front Nutr 8:634897","journal-title":"Front Nutr"},{"key":"5419_CR86","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/jpen.2319","volume":"46","author":"T Liu","year":"2022","unstructured":"Liu T, Wang C, Wang YY, Wang LL, Ojo O, Feng QQ, Jiang XS, Wang XH (2022) Effect of dietary fiber on gut barrier function, gut microbiota, short-chain fatty acids, inflammation, and clinical outcomes in critically ill patients: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 46:997\u20131010","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"5419_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003088-200847030-00005","volume":"47","author":"ED Lobo","year":"2008","unstructured":"Lobo ED, Bergstrom RF, Reddy S, Quinlan T, Chappell J, Hong Q, Ring B, Knadler MP (2008) In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with Duloxetine. Clin Pharmacokinet 47:191\u2013202","journal-title":"Clin Pharmacokinet"},{"key":"5419_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2021.100386","volume":"15","author":"T Louwies","year":"2021","unstructured":"Louwies T, Orock A, Greenwood-Van Meerveld B (2021) Stress-induced visceral pain in female rats is associated with epigenetic remodeling in the central nucleus of the amygdala. Neurobiol Stress 15:100386","journal-title":"Neurobiol Stress"},{"key":"5419_CR89","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10:712-721.e4","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5419_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41398-019-0466-x","volume":"9","author":"I Luki\u0107","year":"2019","unstructured":"Luki\u0107 I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, Elliott E (2019) Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry 9:133","journal-title":"Transl Psychiatry"},{"key":"5419_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4883","volume":"35","author":"D Lupu","year":"2021","unstructured":"Lupu D, Hancu G (2021) Achiral and chiral analysis of Duloxetine by chromatographic and electrophoretic methods, a review on the separation methodologies. Biomed Chromatogr 35:e4883","journal-title":"Biomed Chromatogr"},{"key":"5419_CR92","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.3748\/wjg.v29.i21.3241","volume":"29","author":"VV Lupu","year":"2023","unstructured":"Lupu VV, Ghiciuc CM, Stefanescu G, Mihai CM, Popp A, Sasaran MO, Bozomitu L, Starcea IM, Adam Raileanu A, Lupu A (2023) Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: a literature review. World J Gastroenterol 29:3241\u20133256","journal-title":"World J Gastroenterol"},{"key":"5419_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jad.2016.09.012","volume":"208","author":"D Macedo","year":"2017","unstructured":"Macedo D, Filho A, Soares De Sousa CN, Quevedo J, Barichello T, J\u00fanior HVN, Freitas De Lucena D (2017) Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord 208:22\u201332","journal-title":"J Affect Disord"},{"key":"5419_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713459","author":"J Maciaszek","year":"2023","unstructured":"Maciaszek J, Paw\u0142owski T, Hadry\u015b T, Machowska M, Wiela-Hoje\u0144ska A, Misiak B (2023) The impact of the CYP2D6 and CYP1A2 gene polymorphisms on response to duloxetine in patients with major depression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713459","journal-title":"Int J Mol Sci"},{"key":"5419_CR95","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/nmo.12741","volume":"28","author":"S Mahurkar","year":"2016","unstructured":"Mahurkar S, Polytarchou C, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L (2016) Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome. Neurogastroenterol Motil 28:410\u201322","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR96","doi-asserted-by":"publisher","first-page":"678","DOI":"10.12968\/bjon.2023.32.14.678","volume":"32","author":"S Marks","year":"2023","unstructured":"Marks S (2023) A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome. Br J Nurs 32:678\u2013682","journal-title":"Br J Nurs"},{"key":"5419_CR97","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1176\/appi.psy.50.1.78","volume":"50","author":"PS Masand","year":"2009","unstructured":"Masand PS, Pae CU, Krulewicz S, Peindl K, Mannelli P, Varia IM, Patkar AA (2009) A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics 50:78\u201386","journal-title":"Psychosomatics"},{"key":"5419_CR98","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-med-042320-014032","volume":"73","author":"EA Mayer","year":"2022","unstructured":"Mayer EA, Nance K, Chen S (2022) The gut\u2013brain axis. Annu Rev Med 73:439\u2013453","journal-title":"Annu Rev Med"},{"key":"5419_CR99","doi-asserted-by":"crossref","unstructured":"Mazur M., Furgala A, Jab\u0142o\u0144ski\u00a0K, Mach T, Thor P (2012) Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients. Med Sci Monit\u00a018:Cr493\u2013499","DOI":"10.12659\/MSM.883269"},{"key":"5419_CR100","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neures.2017.06.006","volume":"125","author":"X-W Meng","year":"2017","unstructured":"Meng X-W, Gao J-L, Zuo J-L, Wang L-N, Liu S-L, Jin X-H, Yao M, Namaka M (2017) Toll-like receptor-4\/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain. Neurosci Res 125:37\u201345","journal-title":"Neurosci Res"},{"key":"5419_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00365","volume":"10","author":"J Meng","year":"2019","unstructured":"Meng J, Zhang Q, Yang C, Xiao L, Xue Z, Zhu J (2019) Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-\u03baB. Front Pharmacol 10:365","journal-title":"Front Pharmacol"},{"key":"5419_CR102","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","volume":"158","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S (2001) Occupancy of serotonin transporters by Paroxetine and Citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843\u20131849","journal-title":"Am J Psychiatry"},{"key":"5419_CR103","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-019-0259-y","volume":"17","author":"A Mikocka-Walus","year":"2020","unstructured":"Mikocka-Walus A, Ford AC, Drossman DA (2020) Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17:184\u2013192","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5419_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5056\/jnm24115","volume":"31","author":"Z Mohamedali","year":"2025","unstructured":"Mohamedali Z, Amarasinghe G, Hopkins CWP, Moulton CD (2025) Effect of Buspirone on upper gastrointestinal disorders of gut-brain interaction: a systematic review and meta-analysis. J Neurogastroenterol Motil 31:18\u201327","journal-title":"J Neurogastroenterol Motil"},{"key":"5419_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10354-017-0592-0","volume":"168","author":"G Moser","year":"2018","unstructured":"Moser G, Fournier C, Peter J (2018) Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr 168:62\u201366","journal-title":"Wien Med Wochenschr"},{"key":"5419_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278922","volume":"17","author":"R Nakata","year":"2022","unstructured":"Nakata R, Tanaka F, Sugawara N, Kojima Y, Takeuchi T, Shiba M, Higuchi K, Fujiwara Y (2022) Analysis of autonomic function during natural defecation in patients with irritable bowel syndrome using real-time recording with a wearable device. PLoS One 17:e0278922","journal-title":"PLoS One"},{"key":"5419_CR107","doi-asserted-by":"publisher","unstructured":"Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S, Mandarino FV (2023) Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms 11(10):2369. https:\/\/doi.org\/10.3390\/microorganisms11102369","DOI":"10.3390\/microorganisms11102369"},{"issue":"573\u20138","key":"5419_CR108","volume":"22","author":"SM O'Mahony","year":"2010","unstructured":"O\u2019Mahony SM, Bulmer DC, Coelho AM, Fitzgerald P, Bongiovanni C, Lee K, Winchester W, Dinan TG, Cryan JF (2010) 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 22(573\u20138):e124","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR109","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/rheumatology\/keab146","volume":"60","author":"LF O'mahony","year":"2021","unstructured":"O\u2019mahony LF, Srivastava A, Mehta P, Ciurtin C (2021) Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis. Rheumatology (Oxford) 60:2602\u20132614","journal-title":"Rheumatology (Oxford)"},{"key":"5419_CR110","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbi.2011.04.009","volume":"25","author":"D O'malley","year":"2011","unstructured":"O\u2019malley D, Quigley EM, Dinan TG, Cryan JF (2011) Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav Immun 25:1333\u201341","journal-title":"Brain Behav Immun"},{"key":"5419_CR111","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02191-22","volume":"13","author":"J Ou","year":"2022","unstructured":"Ou J, Elizalde P, Guo HB, Qin H, Tobe BTD, Choy JS (2022) TCA and SSRI antidepressants exert selection pressure for efflux-dependent antibiotic resistance mechanisms in Escherichia coli. mBio 13:e0219122","journal-title":"mBio"},{"key":"5419_CR112","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.chom.2008.05.010","volume":"3","author":"T P\u00e9dron","year":"2008","unstructured":"P\u00e9dron T, Sansonetti P (2008) Commensals, bacterial pathogens and intestinal inflammation: an intriguing m\u00e9nage \u00e0 trois. Cell Host Microbe 3:344\u20137","journal-title":"Cell Host Microbe"},{"key":"5419_CR113","doi-asserted-by":"publisher","unstructured":"Perrelli M, Goparaju P, Postolache TT, Del Bosque-plata L, Gragnoli C (2024) Stress and the CRH system, norepinephrine, depression, and Type 2 diabetes. Biomedicines\u00a012(6):1187. https:\/\/doi.org\/10.3390\/biomedicines12061187","DOI":"10.3390\/biomedicines12061187"},{"key":"5419_CR114","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP (2011) Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 364:22\u201332","journal-title":"N Engl J Med"},{"key":"5419_CR115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P (2019) Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology 157:97\u2013108","journal-title":"Gastroenterology"},{"key":"5419_CR116","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0893-133X(97)00197-8","volume":"18","author":"ML Price","year":"1998","unstructured":"Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I (1998) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492\u2013502","journal-title":"Neuropsychopharmacology"},{"key":"5419_CR117","first-page":"1","volume":"28","author":"V Purshottam","year":"2025","unstructured":"Purshottam V, Tripathi A, Gupta B, Rungta S (2025) A randomized double-blind placebo-controlled trial of add-on duloxetine on symptom severity and quality of life in irritable bowel syndrome. Indian J Behav Sci 28:1\u20139","journal-title":"Indian J Behav Sci"},{"key":"5419_CR118","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.3748\/wjg.v20.i39.14126","volume":"20","author":"HY Qin","year":"2014","unstructured":"Qin HY, Cheng CW, Tang XD, Bian ZX (2014) Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol 20:14126\u201314131","journal-title":"World J Gastroenterol"},{"key":"5419_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106358","volume":"181","author":"X Qin","year":"2023","unstructured":"Qin X, Xie C, Hakenjos JM, Mackenzie KR, Boyd SR, Barzi M, Bissig KD, Young DW, Li F (2023) The roles of Cyp1a2 and Cyp2d in pharmacokinetic profiles of serotonin and norepinephrine reuptake inhibitor duloxetine and its metabolites in mice. Eur J Pharm Sci 181:106358","journal-title":"Eur J Pharm Sci"},{"key":"5419_CR120","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.3748\/wjg.v23.i37.6788","volume":"23","author":"MM Rahman","year":"2017","unstructured":"Rahman MM, Mahadeva S, Ghoshal UC (2017) Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: a review. World J Gastroenterol 23:6788\u20136801","journal-title":"World J Gastroenterol"},{"key":"5419_CR121","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/ajg.2014.427","volume":"110","author":"M Rajili\u0107-Stojanovi\u0107","year":"2015","unstructured":"Rajili\u0107-Stojanovi\u0107 M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, de Vos WM, Manichanh C, Golic N, Enck P, Philippou E, Iraqi FA, Clarke G, Spiller RC, Penders J (2015) Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 110:278\u2013287","journal-title":"Am J Gastroenterol"},{"key":"5419_CR122","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/19490976.2016.1218585","volume":"7","author":"H Raskov","year":"2016","unstructured":"Raskov H, Burcharth J, Pommergaard HC, Rosenberg J (2016) Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes 7:365\u2013383","journal-title":"Gut Microbes"},{"key":"5419_CR123","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","volume":"6","author":"SH Rhee","year":"2009","unstructured":"Rhee SH, Pothoulakis C, Mayer EA (2009) Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:306\u2013314","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5419_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2023.1132127","volume":"17","author":"G Rukavishnikov","year":"2023","unstructured":"Rukavishnikov G, Leonova L, Kasyanov E, Leonov V, Neznanov N, Mazo G (2023) Antimicrobial activity of antidepressants on normal gut microbiota: results of the in vitro study. Front Behav Neurosci 17:1132127","journal-title":"Front Behav Neurosci"},{"key":"5419_CR125","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/art.27304","volume":"62","author":"S Sacre","year":"2010","unstructured":"Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R (2010) Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum 62:683\u2013693","journal-title":"Arthritis Rheum"},{"key":"5419_CR126","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gtc.2010.12.011","volume":"40","author":"YA Saito","year":"2011","unstructured":"Saito YA (2011) The role of genetics in IBS. Gastroenterol Clin North Am 40:45\u201367","journal-title":"Gastroenterol Clin North Am"},{"key":"5419_CR127","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_247_20","volume":"10","author":"R Salehian","year":"2021","unstructured":"Salehian R, Mokhtare M, Ghanbari Jolfaei A, Noorian R (2021) Investigation the effectiveness of Duloxetine in quality of life and symptoms of patients with irritable bowel syndrome. Adv Biomed Res 10:14","journal-title":"Adv Biomed Res"},{"key":"5419_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172779","volume":"12","author":"O Sarid","year":"2017","unstructured":"Sarid O, Slonim-Nevo V, Pereg A, Friger M, Sergienko R, Schwartz D, Greenberg D, Shahar I, Chernin E, Vardi H, Eidelman L, Segal A, Ben-Yakov G, Gaspar N, Munteanu D, Rozental A, Mushkalo A, Dizengof V, Abu-Freha N, Fich A, Odes S (2017) Coping strategies, satisfaction with life, and quality of life in Crohn\u2019s disease: a gender perspective using structural equation modeling analysis. PLoS One 12:e0172779","journal-title":"PLoS One"},{"key":"5419_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2021.110694","volume":"153","author":"SJ Schaper","year":"2022","unstructured":"Schaper SJ, Stengel A (2022) Emotional stress responsivity of patients with IBS - a systematic review. J Psychosom Res 153:110694","journal-title":"J Psychosom Res"},{"key":"5419_CR130","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00213-014-3810-0","volume":"232","author":"K Schmidt","year":"2015","unstructured":"Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW (2015) Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology Berl 232:1793\u20131801","journal-title":"Psychopharmacology Berl"},{"key":"5419_CR131","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/ajg.2010.159","volume":"105","author":"P Scully","year":"2010","unstructured":"Scully P, Mckernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Quigley EM (2010) Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 105:2235\u20132243","journal-title":"Am J Gastroenterol"},{"key":"5419_CR132","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_379_21","volume":"12","author":"MR Sharbafchi","year":"2023","unstructured":"Sharbafchi MR, Afshar Zanjani H, Saneian Z, Feizi A, Daghaghzadeh H, Adibi P (2023) Effects of Duloxetine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome. Adv Biomed Res 12:249","journal-title":"Adv Biomed Res"},{"issue":"Suppl 1","key":"5419_CR133","first-page":"S12","volume":"54","author":"MG Shiha","year":"2021","unstructured":"Shiha MG, Aziz I (2021) Review article: physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther 54(Suppl 1):S12-s23","journal-title":"Aliment Pharmacol Ther"},{"key":"5419_CR134","doi-asserted-by":"publisher","unstructured":"Sic A, Bogicevic M, Brezic N, Nemr C, Knezevic NN (2025) Chronic stress and headaches: the role of the HPA axis and autonomic nervous system. Biomedicines\u00a013(2):463. https:\/\/doi.org\/10.3390\/biomedicines13020463","DOI":"10.3390\/biomedicines13020463"},{"key":"5419_CR135","doi-asserted-by":"publisher","first-page":"135","DOI":"10.51642\/ppmj.v35i04.731","volume":"35","author":"T Siddique","year":"2024","unstructured":"Siddique T, Farzand S, Khalid M, Ahmad R, Ejaz U (2024) Randomized controlled clinical trial to study the effects of Duloxetine alone and in combination with Alpha-Lipoic Acid on symptomatic improvement of diabetic neuropathy. Pak Postgrad Med J 35:135\u2013139","journal-title":"Pak Postgrad Med J"},{"key":"5419_CR136","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000515130","volume":"28","author":"S Silberstein","year":"2021","unstructured":"Silberstein S, Liberman AC, Dos Santos Claro PA, Ugo MB, Deussing JM, Arzt E (2021) Stress-related brain neuroinflammation impact in depression: role of the Corticotropin-Releasing Hormone System and P2X7 Receptor. Neuroimmunomodulation 28:52\u201360","journal-title":"Neuroimmunomodulation"},{"key":"5419_CR137","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","volume":"29","author":"DB Silk","year":"2009","unstructured":"Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29:508\u2013518","journal-title":"Aliment Pharmacol Ther"},{"key":"5419_CR138","doi-asserted-by":"publisher","unstructured":"Sonali S, Ray B, Ahmed Tousif H, Rathipriya AG, Sunanda T, Mahalakshmi AM, Rungratanawanich W, Essa MM, Qoronfleh MW, Chidambaram SB, Song BJ (2022) Mechanistic insights into the link between Gut Dysbiosis and Major Depression: an extensive review. Cells 11(8):1362. https:\/\/doi.org\/10.3390\/cells11081362","DOI":"10.3390\/cells11081362"},{"key":"5419_CR139","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(07)60726-0","volume":"369","author":"R Spiller","year":"2007","unstructured":"Spiller R (2007a) Clinical update: irritable bowel syndrome. Lancet 369:1586\u20138","journal-title":"Lancet"},{"issue":"Suppl 2","key":"5419_CR140","first-page":"S115","volume":"45","author":"R Spiller","year":"2007","unstructured":"Spiller R (2007b) Serotonin, inflammation, and IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr 45(Suppl 2):S115-9","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5419_CR141","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.neuropharm.2008.07.016","volume":"55","author":"R Spiller","year":"2008","unstructured":"Spiller R (2008) Serotonin and GI clinical disorders. Neuropharmacology 55:1072\u20131080","journal-title":"Neuropharmacology"},{"key":"5419_CR142","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00535-012-0627-7","volume":"47","author":"C Stasi","year":"2012","unstructured":"Stasi C, Rosselli M, Bellini M, Laffi G, Milani S (2012) Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 47:1177\u20131185","journal-title":"J Gastroenterol"},{"key":"5419_CR143","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","volume":"66","author":"HM Staudacher","year":"2017","unstructured":"Staudacher HM, Whelan K (2017) The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 66:1517\u20131527","journal-title":"Gut"},{"key":"5419_CR144","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3945\/jn.112.159285","volume":"142","author":"HM Staudacher","year":"2012","unstructured":"Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K (2012) Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 142:1510\u20131518","journal-title":"J Nutr"},{"key":"5419_CR145","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbi.2015.04.003","volume":"48","author":"L Steenbergen","year":"2015","unstructured":"Steenbergen L, Sellaro R, VAN Hemert S, Bosch JA, Colzato LS (2015) A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48:258\u2013264","journal-title":"Brain Behav Immun"},{"key":"5419_CR146","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1258\/ebm.2010.009347","volume":"235","author":"A Stengel","year":"2010","unstructured":"Stengel A, Tach\u00e9 Y (2010) Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) 235:1168\u201378","journal-title":"Exp Biol Med (Maywood)"},{"key":"5419_CR147","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3748\/wjg.v18.i7.616","volume":"18","author":"T Surdea-Blaga","year":"2012","unstructured":"Surdea-Blaga T, B\u0103ban A, Dumitrascu DL (2012) Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 18:616\u2013626","journal-title":"World J Gastroenterol"},{"key":"5419_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2024.2414279","author":"E Suzuki","year":"2024","unstructured":"Suzuki E, Sueki A, Takahashi H, Ishigooka J, Nishimura K (2024) Association between TNF-\u03b1 & IL-6 level changes and remission from depression with duloxetine treatment. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2024.2414279","journal-title":"Int J Neurosci"},{"key":"5419_CR149","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/gut.2005.077503","volume":"55","author":"J Tack","year":"2006","unstructured":"Tack J, Broekaert D, Fischler B, VAN Oudenhove L, Gevers AM, Janssens J (2006) A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 55:1095\u20131103","journal-title":"Gut"},{"key":"5419_CR150","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10620-007-9830-4","volume":"53","author":"NJ Talley","year":"2008","unstructured":"Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M (2008) Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci 53:108\u2013115","journal-title":"Dig Dis Sci"},{"key":"5419_CR151","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-2779","volume":"9","author":"HY Tang","year":"2021","unstructured":"Tang HY, Jiang AJ, Wang XY, Wang H, Guan YY, Li F, Shen GM (2021) Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review. Ann Transl Med 9:1187","journal-title":"Ann Transl Med"},{"key":"5419_CR152","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2036.2007.03399.x","volume":"26","author":"M Thabane","year":"2007","unstructured":"Thabane M, Kottachchi DT, Marshall JK (2007) Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 26:535\u2013544","journal-title":"Aliment Pharmacol Ther"},{"key":"5419_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2020.100216","volume":"12","author":"P Tian","year":"2020","unstructured":"Tian P, O\u2019riordan KJ, Lee YK, Wang G, Zhao J, Zhang H, Cryan JF, Chen W (2020) Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiol Stress 12:100216","journal-title":"Neurobiol Stress"},{"key":"5419_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1175057","volume":"14","author":"S Tian","year":"2023","unstructured":"Tian S, Zhang H, Chen S, Wu P, Chen M (2023) Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis. Front Pharmacol 14:1175057","journal-title":"Front Pharmacol"},{"key":"5419_CR155","doi-asserted-by":"publisher","unstructured":"Tocut M, Halpert G, Tsur AM, Sharif K, Heidecke H, Levy Y, Watad A, Amital H, Shoenfeld Y (2022) Cognitive impairment, sleep disturbance, and depression in women with silicone breast implants: association with autoantibodies against autonomic nervous system receptors. Biomolecules\u00a012(6):776. https:\/\/doi.org\/10.3390\/biom12060776","DOI":"10.3390\/biom12060776"},{"key":"5419_CR156","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fncel.2013.00191","volume":"7","author":"M Tsuda","year":"2013","unstructured":"Tsuda M, Masuda T, Tozaki-Saitoh H, Inoue K (2013) P2X4 receptors and neuropathic pain. Front Cell Neurosci 7:191","journal-title":"Front Cell Neurosci"},{"key":"5419_CR157","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.psyneuen.2016.03.016","volume":"69","author":"EJ Videlock","year":"2016","unstructured":"Videlock EJ, Shih W, Adeyemo M, Mahurkar-Joshi S, Presson AP, Polytarchou C, Alberto M, Iliopoulos D, Mayer EA, Chang L (2016) The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression. Psychoneuroendocrinology 69:67\u201376","journal-title":"Psychoneuroendocrinology"},{"key":"5419_CR158","first-page":"17","volume":"111","author":"AA Villarreal","year":"2012","unstructured":"Villarreal AA, Aberger FJ, Benrud R, Gundrum JD (2012) Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. WMJ 111:17\u201320","journal-title":"WMJ"},{"key":"5419_CR159","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1017\/S0007114515001889","volume":"114","author":"J Vulevic","year":"2015","unstructured":"Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, Gibson GR (2015) Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr 114:586\u2013595","journal-title":"Br J Nutr"},{"key":"5419_CR160","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1113\/EP086110","volume":"102","author":"WS Wan Saudi","year":"2017","unstructured":"Wan Saudi WS, Sj\u00f6blom M (2017) Short\u2010chain fatty acids augment rat duodenal mucosal barrier function. Exp Physiol 102:791\u2013803","journal-title":"Exp Physiol"},{"key":"5419_CR161","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","volume":"57","author":"H-B Wang","year":"2012","unstructured":"Wang H-B, Wang P-Y, Wang X, Wan Y-L, Liu Y-C (2012) Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 57:3126\u20133135","journal-title":"Dig Dis Sci"},{"key":"5419_CR162","doi-asserted-by":"publisher","unstructured":"Wang Z, Liu Y, Peng Y, Peng L (2022) Helicobacterpylori infection-a risk factor for irritable bowel syndrome? An updated systematic review and meta-analysis. Medicina (Kaunas)\u00a058(8):1035. https:\/\/doi.org\/10.3390\/medicina58081035","DOI":"10.3390\/medicina58081035"},{"key":"5419_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01635-6","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou J, Ye J, Sun Z, He Y, Zhao Y, Ren S, Zhang G, Liu M, Zheng P, Wang G, Yang J (2023) Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder. Microbiome 11:195","journal-title":"Microbiome"},{"key":"5419_CR164","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/469439","volume":"2008","author":"F Wesseldijk","year":"2008","unstructured":"Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, Niehof SP, Zijlstra FJ (2008) Six years follow\u2010up of the levels of TNF\u2010\u03b1 and IL\u20106 in patients with complex regional pain syndrome type 1. Mediators of inflammation 2008:469439","journal-title":"Mediators of inflammation"},{"key":"5419_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.759634","volume":"2","author":"AB Willits","year":"2021","unstructured":"Willits AB, Grossi V, Glidden NC, Hyams JS, Young EE (2021) Identification of a pain-specific gene expression profile for pediatric recurrent abdominal pain. Front Pain Res 2:759634","journal-title":"Front Pain Res"},{"key":"5419_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165189","volume":"11","author":"T Yamashita","year":"2016","unstructured":"Yamashita T, Yamamoto S, Zhang J, Kometani M, Tomiyama D, Kohno K, Tozaki-Saitoh H, Inoue K, Tsuda M (2016) Duloxetine inhibits microglial P2X4 receptor function and alleviates neuropathic pain after peripheral nerve injury. PLoS ONE 11:e0165189","journal-title":"PLoS ONE"},{"key":"5419_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1251470","volume":"17","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang J, Zhang C, Guo Y, Zhao M, Zhang M, Li Z, Gao F, Luo Y, Wang Y, Cao J, Du M, Wang Y, Lin X, Xu Z (2023) The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome. Front Neurosci 17:1251470","journal-title":"Front Neurosci"},{"key":"5419_CR168","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/archgenpsychiatry.2008.533","volume":"66","author":"IS Yim","year":"2009","unstructured":"Yim IS, Glynn LM, Dunkel-Schetter C, Hobel CJ, Chicz-Demet A, Sandman CA (2009) Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Arch Gen Psychiatry 66:162\u2013169","journal-title":"Arch Gen Psychiatry"},{"key":"5419_CR169","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/apt.15325","volume":"50","author":"M Zamani","year":"2019","unstructured":"Zamani M, Alizadeh-Tabari S, Zamani V (2019) Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther 50:132\u2013143","journal-title":"Aliment Pharmacol Ther"},{"key":"5419_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104408","volume":"81","author":"MH Zeeshan","year":"2022","unstructured":"Zeeshan MH, Vakkalagadda NP, Sree GS, Anne KK, Devi S, Parkash O, Fawwad SBU, Haider SMW, Mumtaz H, Hasan M (2022) Irritable bowel syndrome in adults: prevalence and risk factors. Ann Med Surg 81:104408","journal-title":"Ann Med Surg"},{"key":"5419_CR171","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijdevneu.2016.09.005","volume":"55","author":"X Zhang","year":"2016","unstructured":"Zhang X, Wang Q, Wang Y, Hu J, Jiang H, Cheng W, Ma Y, Liu M, Sun A, Zhang X (2016a) Duloxetine prevents the effects of prenatal stress on depressive-like and anxiety-like behavior and hippocampal expression of pro-inflammatory cytokines in adult male offspring rats. Int J Dev Neurosci 55:41\u201348","journal-title":"Int J Dev Neurosci"},{"key":"5419_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.557342","volume":"11","author":"F Zhang","year":"2020","unstructured":"Zhang F, Qi N, Zeng Y, Bao M, Chen Y, Liao J, Wei L, Cao D, Huang S, Luo Q, Jiang Y, Mo Z (2020a) The endogenous alterations of the gut microbiota and feces metabolites alleviate oxidative damage in the brain of LanCL1 knockout mice. Front Microbiol 11:557342","journal-title":"Front Microbiol"},{"key":"5419_CR173","first-page":"4354","volume":"13","author":"X Zhang","year":"2020","unstructured":"Zhang X, Gao L, Li H, Jiang Z (2020b) The effects of duloxetine combined with olanzapine on climacteric depression and the neuroendocrine system. Int J Clin Exp Med 13:4354\u20134361","journal-title":"Int J Clin Exp Med"},{"key":"5419_CR174","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1007\/s10620-024-08671-8","volume":"69","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu P, Xu Y, Lu XY, Xu Y, Hang J, Zhang Y (2024) Efficacy and safety of a low-FODMAP diet in combination with a gluten-free diet for adult irritable bowel syndrome: a systematic review and meta-analysis. Dig Dis Sci 69:4124\u20134132","journal-title":"Dig Dis Sci"},{"key":"5419_CR175","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14299","volume":"34","author":"L Zhao","year":"2022","unstructured":"Zhao L, Ren P, Wang M, Wang J, He X, Gu J, Lu Y, Wu Y, Liu J, Wang L, Li H (2022) Changes in intestinal barrier protein expression and intestinal flora in a rat model of visceral hypersensitivity. Neurogastroenterol Motil 34:e14299","journal-title":"Neurogastroenterol Motil"},{"key":"5419_CR176","doi-asserted-by":"crossref","unstructured":"Zhou SY, Gillilland M 3RD, Wu X, Leelasinjaroen P, Zhang G, Zhou H, Ye B, Lu Y, Owyang C (2018) FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest 128:267\u2013280","DOI":"10.1172\/JCI92390"},{"key":"5419_CR177","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fpsyt.2018.00442","volume":"9","author":"C Zhu","year":"2018","unstructured":"Zhu C, Xu J, Lin Y, Ju P, Duan D, Luo Y, Ding W, Huang S, Chen J, Cui D (2018) Loss of microglia and impaired brain-neurotrophic factor signaling pathway in a comorbid model of chronic pain and depression. Front Psychiatry 9:442","journal-title":"Front Psychiatry"},{"key":"5419_CR178","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11302-021-09801-x","volume":"19","author":"Y Zou","year":"2023","unstructured":"Zou Y, Yang R, Li L, Xu X, Liang S (2023) Purinergic signaling: a potential therapeutic target for depression and chronic pain. Purinergic Signal 19:163\u2013172","journal-title":"Purinergic Signal"},{"key":"5419_CR179","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/gut.2011.241877","volume":"60","author":"M Zucchelli","year":"2011","unstructured":"Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, T\u00f6rkvist L, Schmidt PT, Karling P, Ohlsson B, Duerr RH, Simren M, Lindberg G, Agreus L, Carlson P, Zinsmeister AR, D\u2019amato M (2011) Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 60:1671\u20131677","journal-title":"Gut"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05419-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:01:50Z","timestamp":1787677310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05419-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":179,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5419"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05419-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}